In this video, we will build a dynamic monthly budgeting and forecasting model in Excel, known as a rolling 12-month forecast ...
Veeva Systems (VEEV) analysis: revenue up 16%, improving margins, Vault CRM transition risks, and a $267 DCF target (32% upside).
Corcept Therapeutics remains a 'Hold' as LIFYORLI's strong launch and clinical demand are already reflected in a premium valuation. LIFYORLI generated $47.6M in its first full quarter, with management ...